Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Expert Opinion on Therapeutic Targets|September 28, 2005
Vasoactive intestinal peptide family as a therapeutic target for Parkinson's diseaseElena Gonzalez-Rey, Alejo Chorny, Amelia Fernandez-Martin, et al.
Blood|January 19, 2006
Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor responseAlejo Chorny, Elena Gonzalez-Rey, Amelia Fernandez-Martin, et al.
European Journal of Immunology|January 13, 2006
Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitisAmelia Fernandez-Martin, Elena Gonzalez-Rey, Alejo Chorny, et al.
Blood|January 7, 2006
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cellsElena Gonzalez-Rey, Alejo Chorny, Amelia Fernandez-Martin, et al.
Arthritis and Rheumatism|April 1, 2009
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cellsManuel A González, Elena Gonzalez-Rey, Laura Rico, et al.
Gastroenterology|January 13, 2009
Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responsesManuel A González, Elena Gonzalez-Rey, Laura Rico, et al.
Annals of the New York Academy of Sciences|May 9, 2015
Lulling immunity, pain, and stress to sleep with cortistatinElena Gonzalez-Rey, Marta Pedreño, Virginia Delgado-Maroto, et al.
Peptides|May 25, 2007
Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersDavid Pozo, Elena Gonzalez-Rey, Alejo Chorny, et al.
Annals of the Rheumatic Diseases|December 8, 2006
Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responsesElena Gonzalez-Rey, Alejo Chorny, Raimundo G Del Moral, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disordersAlejo Chorny, Elena Gonzalez-Rey, Amelia Fernandez-Martin, et al.
Pageof 9